ADHD 
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for ADHD trials

Effective solutions for advancing ADHD research

While considerable advancements in the clinical understanding of ADHD have led to effective treatment options, there is still need for the development of new medications and improved therapeutic strategies.

Signant's technology solutions and unrivaled scientific expertise help sponsors and CROs capture high quality, reliable evidence while streamlining the clinical trial experience for patients and sites.

Navigate ADHD Trial Challenges & Meet Your Goals

  • Capture Reliable COA Data
  • Train & Calibrate Raters
  • Ensure Comprehension
  • Work With ADHD Experts
  • Maximize Supplies Efficiency
  • Capture Reliable COA Data

    Capture Reliable COA Data

    Patient-reported and clinician-reported outcome assessments are vital to fully evaluate ADHD treatment risk-benefit profiles. Our eCOA solution can be tailored to sites' and patients' needs – guided assessments and built-in edit checks reduce COA errors, while alerts and reminders help improve adherence to medication dosing and assessment schedules.

  • Train & Calibrate Raters

    Train & Calibrate Raters

    Train and monitor your study's raters to ensure consistency and accuracy with Signant's Rater Training and Central Review services. Our experts ensure raters adhere to eligibility criteria and score diagnostic/efficacy measures correctly, and they can help mitigate excessive placebo response to improve your ADHD study’s data reliability.

  • Ensure Comprehension

    Ensure Comprehension

    Signant’s robust eConsent platform employs multimedia, managed interactions, content flagging, and virtual visits to help participants and caregivers comprehend your protocol requirements. Plus, automated version control ensures only the most recently approved document version is presented.

  • Work With ADHD Experts

    Work With ADHD Experts

    From consulting on outcome measure selection and implementation to data quality management strategies, Signant’s in-house experts will help you navigate common ADHD challenges throughout the study lifecycle. Talk through your protocol with our CNS and pediatric research experts well-versed in ADHD protocols.

  • Maximize Supplies Efficiency

    Maximize Supplies Efficiency

    Take control of product management complexities and simplify randomization for multi-arm trial designs with Signant's global RTSM solution. Study teams trust our solution to not only launch studies faster but to handle patient cohorts, study supply forecasting, mid-study changes, and data transfers with efficiency and accuracy.

Extensive ADHD Experience

0

TRIALS

0

COUNTRIES

0

PATIENTS

0

SITES

Explore Our ADHD Trial Resources
SOLUTION BROCHURE

ADHD Trial Solutions Overview

GET INSIGHTS
VIDEO

ADHD Trial Solutions


WATCH [2 MIN]
CASE STUDY

Signant SmartSignals eConsent for Japanese Pediatric Psychiatry Study

READ CASE STUDY

Ready to learn more?

Discover how Signant can support your current or upcoming ADHD trials.